Found: 6
Select item for more details and to access through your institution.
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis.
- Published in:
- Clinical & Experimental Metastasis, 2005, v. 22, n. 5, p. 429, doi. 10.1007/s10585-005-2669-1
- By:
- Publication type:
- Article
Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1316, doi. 10.1111/dom.13278
- By:
- Publication type:
- Article
A phase 3 multicenter, open‐label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting
- Published in:
- Pediatric Diabetes, 2018, v. 19, n. 5, p. 1007, doi. 10.1111/pedi.12668
- By:
- Publication type:
- Article
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.
- Published in:
- 2016
- By:
- Publication type:
- letter
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article